The effect of prenylamine on the QT interval of the resting electrocardiogram in patients with angina pectoris
Open Access
- 1 November 1980
- journal article
- research article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 56 (661), 753-756
- https://doi.org/10.1136/pgmj.56.661.753
Abstract
Resting ECGs were recorded in 29 patients with angina pectoris before, during and after treatment with prenylamine 180 mg daily. The QT interval became significantly prolonged after one week of treatment. The prolongation persisted as long as therapy was continued, which was up to 6 months. After withdrawal of treatment the QT interval returned to normal within 2 weeks. In this study no serious problems were encountered by those patients in whom the QT interval was prolonged.Keywords
This publication has 7 references indexed in Scilit:
- Atypical ventricular tachycardia as a manifestation of disopyramide toxicityThe American Journal of Cardiology, 1978
- Ventricular arrhythmias caused by prenylamine.BMJ, 1977
- [Adverse effects of drugs: syncope due to prenylamine (author's transl)].1976
- Prenylamine in treatment of angina.Heart, 1974
- [Syncope by volley of ventricular spikes induced or encouraged by prenylamine].1973
- UNTERSUCHUNGEN UBER DIE FLIMMERWIDRIGE WIRKUNG DES N-(3'-PHENYL-PROPYL-(2'))-1,1-DIPHENYLPROPYL-(3)-AMINS (SEGONTIN)1963
- Utility and limitations of intravenous quinidine in arrhythmiasAmerican Heart Journal, 1951